In adults with dyspepsia younger than 55 and no alarm symptoms, which strategy is appropriate?

In adults with dyspepsia younger than 55 and no alarm symptoms, which strategy is appropriate?

• A. Test and treat for H pylori
• B. Endoscopy to rule out cancer
• C. Empiric proton pump inhibitor therapy without testing
• D. No testing or treatment

Answer: (A)

In adults with dyspepsia who are younger than 55 and have no alarming symptoms, starting with noninvasive testing for Helicobacter pylori and treating if positive is a practical, efficient first step. H. pylori is a common, treatable cause of dyspepsia, and eradicating the infection can relieve symptoms in many patients. This approach targets a likely underlying cause without jumping to invasive procedures. Endoscopy to rule out cancer isn’t typically needed in someone under 55 without alarm features, because the probability of malignancy is very low in this group and endoscopy carries more risk and cost. Empiric PPI therapy without testing is reasonable for some patients, but it doesn’t identify and address H. pylori when present, potentially leaving a curable cause untreated. Not testing or treating at all misses the chance to cure a common, treatable condition and may lead to ongoing symptoms or progression. Thus, test and treat for H. pylori is the most appropriate initial strategy in this clinical scenario.

In adults with dyspepsia who are younger than 55 and have no alarming symptoms, starting with noninvasive testing for Helicobacter pylori and treating if positive is a practical, efficient first step. H. pylori is a common, treatable cause of dyspepsia, and eradicating the infection can relieve symptoms in many patients. This approach targets a likely underlying cause without jumping to invasive procedures.

Endoscopy to rule out cancer isn’t typically needed in someone under 55 without alarm features, because the probability of malignancy is very low in this group and endoscopy carries more risk and cost. Empiric PPI therapy without testing is reasonable for some patients, but it doesn’t identify and address H. pylori when present, potentially leaving a curable cause untreated. Not testing or treating at all misses the chance to cure a common, treatable condition and may lead to ongoing symptoms or progression.

Thus, test and treat for H. pylori is the most appropriate initial strategy in this clinical scenario.